HOOKIPA Pharma Inc. Quarterly Operating Margin in % from Q1 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
HOOKIPA Pharma Inc. quarterly/annual Operating Margin history and growth rate from Q1 2019 to Q2 2024.
  • HOOKIPA Pharma Inc. Operating Margin for the quarter ending June 30, 2024 was -124 %, a 74.8% increase year-over-year.
  • HOOKIPA Pharma Inc. annual Operating Margin for 2023 was -485 %, a 5.47% increase from 2022.
  • HOOKIPA Pharma Inc. annual Operating Margin for 2022 was -513 %, a 16% decline from 2021.
  • HOOKIPA Pharma Inc. annual Operating Margin for 2021 was -443 %, a 62.7% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -124 +370 +74.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -119 +354 +74.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -485 +28.1 +5.47% Oct 1, 2023 Dec 31, 2023
Q3 2023 -391 +400 +50.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -495 +189 +27.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -474 +92.9 +16.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -513 -70.7 -16% Oct 1, 2022 Dec 31, 2022
Q3 2022 -791 -412 -108% Jul 1, 2022 Sep 30, 2022
Q2 2022 -684 -331 -94.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -566 -283 -100% Jan 1, 2022 Mar 31, 2022
Q4 2021 -443 -171 -62.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -379 -95 -33.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -352 -50.1 -16.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -283 +111 +28.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -272 +156 +36.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -284 +14.4 +4.82% Jul 1, 2020 Sep 30, 2020
Q2 2020 -302 -60.8 -25.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -395 -137 -53.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -428 Oct 1, 2019 Dec 31, 2019
Q3 2019 -299 Jul 1, 2019 Sep 30, 2019
Q2 2019 -242 Apr 1, 2019 Jun 30, 2019
Q1 2019 -257 Jan 1, 2019 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.